. .may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful . .the provider paid out on 7,469 life and 1,769 critical illness claims in the year, with men accounting for 59 per cent of life claims and 47 per cent of critical illness claims. . . . http://lm360.us/Bredehoft-daughter-of-Severtson-from-Calgary?Poetzschg=120 . .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .total digital access /week